Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.

Low-Level Light Therapy is effective for skin rejuvenation, wound healing, and hair growth, with mild side effects.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

Tofacitinib may help treat severe hair loss, but more research is needed.

Gene therapy shows promise for treating skin disorders and cancer, but faces technical challenges.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

New antifungal treatments for a children's scalp infection are effective and safe, but it's not decided if they will become the preferred option over the old treatment.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

People with cleft lip and palate often have respiratory problems.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Second-generation antipsychotics offer no significant benefit over first-generation ones for schizophrenia.

Blocking the prolactin receptor might help treat various diseases, but more research is needed.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

HIF-1A may aid hair growth, Backhousia citriodora improves skin, autologous cells stabilize hair loss, infrared thermography assesses alopecia, and a new treatment preserves hair.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Sodium selenate was found to be safe and possibly slows Alzheimer's progression, but more research is needed.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

PROTACs offer new ways to treat hard-to-target diseases, with promising drugs for cancer in advanced trials.

Six African American women experienced hair loss after switching to a new HIV medication.

Tofacitinib may help regrow hair in alopecia areata patients.